INSERM U522, IFR 140, Université de Rennes 1, Hôpital Pontchaillou, Rennes, France.
J Hepatol. 2010 Mar;52(3):398-406. doi: 10.1016/j.jhep.2009.12.009. Epub 2010 Jan 17.
BACKGROUND & AIMS: Imaging of supramolecular structures by multiphoton microscopy offers significant advantages for studying specific fibrillar compounds in biological tissues. In this study, we aimed to demonstrate the relevance of Second Harmonic Generation (SHG) for assessing and quantifying, without staining, fibrillar collagen in liver fibrosis.
We first showed the relationship between SHG signal and collagen forms over-produced and accumulated during fibrosis progression. Taking this property into consideration, we developed an innovative method to precisely quantify the fibrosis area in histological slices by scoring of fibrillar collagen deposits (Fibrosis-SHG index).
The scoring method was routinely applied to 119 biopsies from patients with chronic liver disease allowing a fast and accurate measurement of fibrosis correlated with the Fibrosis-Metavir score (rho=0.75, p<0.0001). The technique allowed discriminating patients with advanced (moderate to severe) fibrosis (AUROC=0.88, p<0.0001) and cirrhosis (AUROC=0.89, p<0.0001). Taking advantage of its continuous gradation, the Fibrosis-SHG index also allowed the discrimination of several levels of fibrosis within the same F-Metavir stage. The SHG process presented several advantages such as a high reliability and sensitivity that lead to a standardized evaluation of hepatic fibrosis in liver biopsies without staining and pathological examination.
Second harmonic microscopy emerges as an original and powerful tool in the assessment of liver fibrosis and offers new possibilities for the evaluation of experimental protocols. We expect that this technology could easily be applicable in the study of other fibro-proliferative pathologies.
多光子显微镜对超分子结构的成像,为研究生物组织中特定纤维状化合物提供了显著优势。本研究旨在证明二次谐波产生(SHG)在评估和定量肝纤维化中无染色纤维状胶原方面的相关性。
我们首先展示了 SHG 信号与纤维化过程中过度产生和积累的胶原形式之间的关系。考虑到这一特性,我们开发了一种创新方法,通过对纤维状胶原沉积物(纤维化-SHG 指数)进行评分,精确量化组织学切片中的纤维化区域。
该评分方法常规应用于 119 例慢性肝病患者的活检,能够快速准确地测量与纤维化-梅特维尔评分相关的纤维化(rho=0.75,p<0.0001)。该技术能够区分进展期(中至重度)纤维化(AUROC=0.88,p<0.0001)和肝硬化(AUROC=0.89,p<0.0001)患者。利用其连续分级,纤维化-SHG 指数还能够区分同一 F-Metavir 阶段内的几个纤维化水平。SHG 过程具有高可靠性和灵敏度等优势,可实现肝活检中纤维化的无染色和病理检查的标准化评估。
二次谐波显微镜成为评估肝纤维化的一种新颖且强大的工具,并为实验方案的评估提供了新的可能性。我们预计,该技术易于应用于其他纤维增生性病理学的研究。